https://www.selleckchem.com/pr....oducts/jak-inhibitor
Clinical characteristics and ovarian response parameters were comparable between the three groups. Type of cancer was not a predictor for number of mature oocytes (p = 0.329), oocyte-maturity index (p = 0.815), or oocyte yield, (p = 0.161) after adjustment to cycle covariates. Moreover, cancer did not have impact on the number of mature oocytes (p = 0.699), oocyte-maturity index (p = 0.251) and oocyte yield (p = 0.094). There is no difference observed in outcomes of ovarian stimulation based on primary cancer diagnosis in oncofe
Synes godt om
Kommentar
Del
